8:19 PM 28th September 2023
Flu And COVID-19 Surveillance Report Published - 28 September 2023
This fortnightly flu and COVID-19 report brings together the latest surveillance data along with the latest public health advice.
COVID-19 surveillance up until end of week 38
Image by Gerd Altmann from Pixabay
Multiple indicators show that COVID-19 case rates have remained stable compared to our previous report.
A total 10.4% of 4,898 respiratory specimens reported through the Respiratory DataMart System were identified as COVID-19. This is compared to 10.2% of 3,297 from the previous report.
The overall COVID-19 hospital admission rate remained stable at 4.36 per 100,000 population, compared to 4.56 per 100,000 from the previous report.
Intensive care units’ (ICU) admission rates for this week’s report were 0.14 per 100,000 population, continuing to remain low and stable from 0.11 per 100,000 from the previous report.
Hospital admission rates for those aged 5 to 14 years and those aged 45 years and over have all decreased, while those aged 0 to 4 years and 15 to 44 years have remained stable.
Those aged 85 years and over continue to have the highest hospital admission rates; these have decreased to 44.86 per 100,000 population from 51.08 per 100,000 in the previous report. Admission rates among those aged 75 to 84 years have decreased to 20.20 per 100,000 population from 21.19 per 100,000 in the previous report.
Dr Jamie Lopez Bernal, Consultant Epidemiologist for Immunisation at the UK Health Security Agency (UKHSA), said:
"In this week’s report, we see multiple indicators point to the stabilisation of COVID-19 rates. We have also seen a decrease in hospitalisation in those aged over 75 compared to 2 weeks ago since our last report. While this is good news, we will continue to remain vigilant and monitor rates closely.
"The NHS booking system for the COVID-19 vaccine is now live. We urge everyone eligible to come forward to boost their protection, and to keep the vulnerable around them safe this winter. Vaccination continues to provide the best protection against serious illness and hospitalisation from COVID-19."